Duavee (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Duavee drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [Chemical/Ingredient],Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | conjugated estrogens/bazedoxifene |
| SUBSTANCE NAME: | ESTROGENS, CONJUGATED; BAZEDOXIFENE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [Chemical/Ingredient],Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-10-03 |
| END MARKETING DATE: | 0000-00-00 |
Duavee HUMAN PRESCRIPTION DRUG Details:
| Item Description | Duavee from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .45; 20(mg/1; mg/1) |
| START MARKETING DATE: | 2013-10-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0008-1123_e61bb558-6bf7-4a6c-a4cd-bbb8f96e4e54 |
| PRODUCT NDC: | 0008-1123 |
| APPLICATION NUMBER: | NDA022247 |
Other ESTROGENS, CONJUGATED; BAZEDOXIFENE ACETATE Pharmaceutical Manufacturers / Labelers:
